81
Participants
Start Date
May 31, 2010
Primary Completion Date
March 31, 2011
Study Completion Date
March 31, 2011
BMS-770767
Active, Oral, 15 mg, Daily, 28 days
BMS-770767
Active, Oral, 50 mg, Daily, 28 days
BMS-770767
Active, Oral, 150 mg, Daily, 28 days
BMS-770767
Active, Oral, 50 mg BID, Daily, 28 days
Placebo
Placebo, Oral, 0 mg, daily, 28 days
Local Institution, Hornsby
Local Institution, Blacktown
Local Institution, South Brisbane
Local Institution, Caboolture
Local Institution, Daw Park
Local Institution, Nedlands
Harrell, Robert, Little Rock
Cetero Research - San Antonio, San Antonio
Local Institution, Bathurst
Local Institution, Brampton
Local Institution, Toronto
Local Institution, Charlottetown
Local Institution, Mirabel
Local Institution, Montreal
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY